Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. [electronic resource]
Producer: 20060302Description: 885-91 p. digitalISSN:- 0006-4971
- Adult
- Age Factors
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Infections -- etiology
- Infusions, Intravenous
- Leukemia, Lymphocytic, Chronic, B-Cell -- complications
- Leukopenia -- chemically induced
- Male
- Middle Aged
- Remission Induction
- Retrospective Studies
- Thrombocytopenia -- chemically induced
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.